|
ZNF680 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33226762955019E-14 |
| Normal-vs-Stage2 |
5.19079999983241E-07 |
| Normal-vs-Stage3 |
5.21804821573824E-13 |
| Normal-vs-Stage4 |
2.56461518688411E-14 |
| Stage1-vs-Stage2 |
3.652400E-01 |
| Stage1-vs-Stage3 |
1.404830E-01 |
| Stage1-vs-Stage4 |
1.097310E-03 |
| Stage2-vs-Stage3 |
7.812000E-02 |
| Stage2-vs-Stage4 |
1.858300E-03 |
| Stage3-vs-Stage4 |
1.172770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.04399999998994E-05 |
| Normal-vs-Asian |
2.04479766452437E-11 |
| Caucasian-vs-AfricanAmerican |
4.346400E-01 |
| Caucasian-vs-Asian |
6.082200E-01 |
| AfricanAmerican-vs-Asian |
2.453200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.85087533977457E-14 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
6.474000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.46924702906881E-12 |
| Normal-vs-Age(41-60Yrs) |
4.30100399739786E-13 |
| Normal-vs-Age(61-80Yrs) |
8.04722954939052E-12 |
| Normal-vs-Age(81-100Yrs) |
6.804600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.819400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.799000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.751600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.094000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.507600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.233400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.499270E-03 |
| Classical-VS-Follicular |
4.164900E-03 |
| Classical-VS-Other |
8.316600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.42669999997547E-06 |
| Tall-VS-Other |
1.918200E-01 |
| Tall-VS-Normal |
1.6716628081781E-12 |
| Follicular-VS-Other |
2.990800E-01 |
| Follicular-VS-Normal |
1.76819999997413E-06 |
| Other-VS-Normal |
2.004000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.89621709632138E-13 |
| Normal-vs-N1 |
9.0738527802614E-13 |
| N0-vs-N1 |
4.072100E-02 |
|
|
